UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

1012 Evaluation of lymph node recurrent prostate cancer with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: Validation by histological analysis

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e1012-e1012a

2012

Volltextzugriff (PDF)

1045 A new proposal for t1, high grade bladder cancer micro-staging definition

European urology supplements : official journal of the European Association of Urology, 2015-04, Vol.14 (2), p.e1045-e1045a

2015

Volltextzugriff (PDF)

1079 RADICAL PROSTATECTOMY AFTER PREVIOUS PROSTATE SURGERY: CLINICAL AND FUNCTIONAL OUTCOMES

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.332-332

2011

Volltextzugriff (PDF)

122 A single positive lymph node has no detrimental effect on survival of patients with prostate cancer treated with extended pelvic lymph node dissection. Results of a matched controlled analysis

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e122-e122

2012

Volltextzugriff (PDF)

128Definitive histopathologic diagnosis on prostate biopsies in 3 hours

European urology supplements : official journal of the European Association of Urology, 2005-03, Vol.4 (3), p.34-34

2005

Volltextzugriff (PDF)

1363P - A multivariate model to define prognostic groups among patients with melanoma brain metastases: A 10-year retrospective cohort study

Annals of oncology, 2019-10, Vol.30, p.v556-v556

2019

Volltextzugriff (PDF)

1363PA multivariate model to define prognostic groups among patients with melanoma brain metastases: A 10-year retrospective cohort study

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

137 PHI (Prostate Health Index) and %p2PSA for prediction of prostate cancer in men younger than 60 years of age. A nested-case control study from PROpsa Multicentric European Study (PROMEtheuS project)

European urology supplements : official journal of the European Association of Urology, 2013-03, Vol.12 (1), p.e137-e138

2013

Volltextzugriff (PDF)

23 A PROPOSAL FOR THE IDEAL SAMPLING SCHEME IN PROSTATE REPEATED BIOPSIES: A RECURSIVE PARTITIONING ANALYSIS BASED ON 24-CORE SYSTEMATIC BIOPSY

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.41-41

2010

Volltextzugriff (PDF)

278 Correlation of chronic histologic prostatic inflammation (CHPI) in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA and PHI (prostate health index) in men undergoing prostate biopsy for suspected PCa

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e278-e278

2012

Volltextzugriff (PDF)

309 - The role of histologic subtypes in follow-up scheme of postsurgical kidney cancer patients

European urology supplements : official journal of the European Association of Urology, 2018-03, Vol.17 (2), p.e435-e435

2018

Volltextzugriff (PDF)

32 PREOPERATIVE CIRCULATING ESTRADIOL, TESTOSTERONE AND SEX HORMONE BINDING GLOBULIN ARE NOT PREDICTORS OF POSITIVE SURGICAL MARGINS AT OPEN RADICAL PROSTATECTOMY

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.44-44

2010

Volltextzugriff (PDF)

3D ultrasound centerline tracking of abdominal vessels for endovascular navigation

International journal for computer assisted radiology and surgery, 2014, Vol.9 (1), p.127-135

2014

Volltextzugriff (PDF)

429 NEOADJUVANT INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN VERSUS STANDARD SCHEDULE FOR NON MUSCLE INVASIVE BLADDER CANCER. RANDOMIZED PHASE II STUDY

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.148-148

2011

Volltextzugriff (PDF)

449 DIFFERENT SURVIVAL OF HISTOLOGIC SUBTYPE IN PATIENTS WITH RENAL RENAL CELL CARCINOMA

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.161-162

2010

Volltextzugriff (PDF)

48 LIDOCAINE METABOLITE (MEGX) FORMATION CORRELATES WITH VINORELBIN CLEARANCE IN PATIENTS WITH METASTATIC BREAST CANCER

Therapeutic drug monitoring, 1995-08, Vol.17 (4), p.395

1995

Volltextzugriff (PDF)

506 - Does the inclusion of non-index lesions at biopsy improve our ability to predict adverse pathologic outcomes at radical prostatectomy? Implications for targeted plus systematic biopsy schemes

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e877-e878

2017

Volltextzugriff (PDF)

534 SINGLE MINUTE FOCUS OF PROSTATE CANCER ON NEEDLE BIOPSY: PREDICTING FACTORS FOR A LOCALLY ADVANCED PROSTATE CANCER ON RADICAL PROSTATECTOMY AND DEVELOPMENT OF A NOMOGRAM

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.178-178

2011

Volltextzugriff (PDF)

559 THE EXTENT OF PELVIC LYMPH NODE DISSECTION DOES NOT AFFECT THE RATE OF ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RETROPUBIC RADICAL PROSTATECTOMY

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.184-185

2011

Volltextzugriff (PDF)

682 ROLE OF POSITIVE SURGICAL MARGINS IN PATIENTS WITH ORGAN CONFINED PROSTATE CANCER. IMPLICATIONS FOR ADJUVANT TREATMENTS

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.224-224

2010

Volltextzugriff (PDF)

698 INITIAL EXTENDED TRANSRECTAL PROSTATIC BIOPSY: DO 18 CORES DETECT MORE PROSTATIC CANCERS THAN 12 CORES?

European urology supplements : official journal of the European Association of Urology, 2007, Vol.6 (2), p.197-197

2007

Volltextzugriff (PDF)

744 The number of cores taken at first negative biopsy does not affect the cancer detection rate at saturation repeat biopsy in patients with persistent suspicion of prostate cancer

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e744-e744

2014

Volltextzugriff (PDF)

800P Number needed to treat (NNT) and number needed to harm (NNH) to estimate clinical efficacy and safety of new adjuvant (Adj) therapies for resected stage (St) II-III melanoma

Annals of oncology, 2022-09, Vol.33, p.S910

2022

Volltextzugriff (PDF)

827Clinical and pathological features of patients with prostate cancer and bone metastases at the diagnosis

European urology supplements : official journal of the European Association of Urology, 2005-03, Vol.4 (3), p.209-209

2005

Volltextzugriff (PDF)

835 HIGH-GRADE PIN DIAGNOSIS: THE IMPACT OF THE NUMBER OF BIOPSY CORES AT INITIAL SAMPLING ON CANCER DETECTION AFTER A SATURATION RE-BIOPSY

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.329-329

2009

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(187)
Mit Volltextzugriff
(212)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

1012 Evaluation of lymph node recurrent prostate cancer with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: Validation by histological analysis

1045 A new proposal for t1, high grade bladder cancer micro-staging definition

1079 RADICAL PROSTATECTOMY AFTER PREVIOUS PROSTATE SURGERY: CLINICAL AND FUNCTIONAL OUTCOMES

122 A single positive lymph node has no detrimental effect on survival of patients with prostate cancer treated with extended pelvic lymph node dissection. Results of a matched controlled analysis

128Definitive histopathologic diagnosis on prostate biopsies in 3 hours

1363P - A multivariate model to define prognostic groups among patients with melanoma brain metastases: A 10-year retrospective cohort study

1363PA multivariate model to define prognostic groups among patients with melanoma brain metastases: A 10-year retrospective cohort study

137 PHI (Prostate Health Index) and %p2PSA for prediction of prostate cancer in men younger than 60 years of age. A nested-case control study from PROpsa Multicentric European Study (PROMEtheuS project)

23 A PROPOSAL FOR THE IDEAL SAMPLING SCHEME IN PROSTATE REPEATED BIOPSIES: A RECURSIVE PARTITIONING ANALYSIS BASED ON 24-CORE SYSTEMATIC BIOPSY

278 Correlation of chronic histologic prostatic inflammation (CHPI) in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA and PHI (prostate health index) in men undergoing prostate biopsy for suspected PCa

309 - The role of histologic subtypes in follow-up scheme of postsurgical kidney cancer patients

32 PREOPERATIVE CIRCULATING ESTRADIOL, TESTOSTERONE AND SEX HORMONE BINDING GLOBULIN ARE NOT PREDICTORS OF POSITIVE SURGICAL MARGINS AT OPEN RADICAL PROSTATECTOMY

3D ultrasound centerline tracking of abdominal vessels for endovascular navigation

429 NEOADJUVANT INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN VERSUS STANDARD SCHEDULE FOR NON MUSCLE INVASIVE BLADDER CANCER. RANDOMIZED PHASE II STUDY

449 DIFFERENT SURVIVAL OF HISTOLOGIC SUBTYPE IN PATIENTS WITH RENAL RENAL CELL CARCINOMA

48 LIDOCAINE METABOLITE (MEGX) FORMATION CORRELATES WITH VINORELBIN CLEARANCE IN PATIENTS WITH METASTATIC BREAST CANCER

506 - Does the inclusion of non-index lesions at biopsy improve our ability to predict adverse pathologic outcomes at radical prostatectomy? Implications for targeted plus systematic biopsy schemes

534 SINGLE MINUTE FOCUS OF PROSTATE CANCER ON NEEDLE BIOPSY: PREDICTING FACTORS FOR A LOCALLY ADVANCED PROSTATE CANCER ON RADICAL PROSTATECTOMY AND DEVELOPMENT OF A NOMOGRAM

559 THE EXTENT OF PELVIC LYMPH NODE DISSECTION DOES NOT AFFECT THE RATE OF ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RETROPUBIC RADICAL PROSTATECTOMY

682 ROLE OF POSITIVE SURGICAL MARGINS IN PATIENTS WITH ORGAN CONFINED PROSTATE CANCER. IMPLICATIONS FOR ADJUVANT TREATMENTS

698 INITIAL EXTENDED TRANSRECTAL PROSTATIC BIOPSY: DO 18 CORES DETECT MORE PROSTATIC CANCERS THAN 12 CORES?

744 The number of cores taken at first negative biopsy does not affect the cancer detection rate at saturation repeat biopsy in patients with persistent suspicion of prostate cancer

800P Number needed to treat (NNT) and number needed to harm (NNH) to estimate clinical efficacy and safety of new adjuvant (Adj) therapies for resected stage (St) II-III melanoma

827Clinical and pathological features of patients with prostate cancer and bone metastases at the diagnosis

835 HIGH-GRADE PIN DIAGNOSIS: THE IMPACT OF THE NUMBER OF BIOPSY CORES AT INITIAL SAMPLING ON CANCER DETECTION AFTER A SATURATION RE-BIOPSY

Suchergebnisse filtern